Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 3 days ago Drug news

CHMP recommends approval of Tookad (padeliporfin) for adenocarcinoma of the prostate.- STEBA Biotech.

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation...

Added 4 days ago Drug news

Independent data monitoring committee determines that Phase III study of Prostvac in prostate cancer should not continue.- Bavarian Nordic.

Bavarian Nordic A/S announced that an independent Data Monitoring Committee (DMCB) has determined, based on a preplanned interim analysis, that...

Added 5 days ago Drug news

Phase III PROSPER trial of Xtandi (enzalutamide) plus androgen deprivation therapy (ADT) versus ADT alone for non-metastatic castration-resistant prostate cancer met its primary endpoint of improved metastasis-free survival.- Pfizer + Astellas

Pfizer Inc.and Astellas Pharma Inc. have announced that the Phase III PROSPER trial evaluating Xtandi (enzalutamide) plus androgen deprivation therapy...

Search all news articles for Men's health/andrology
 

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Hypogonadism

Epidemiology, pathophysiology, diagnosis/treatment guidelines, recent publication summaries and more.

Visit Hypogonadism

Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

+ 1 more

Visit Prostate Cancer

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

Visit Chronic Lymphocytic Leukaemia (CLL)

 

Guidelines

Guidelines on Male Sexual Dysfunction

These guidelines include 4 sections. The aim of the first two sections is to present the current evidence for the...

Added 1 year ago

EAU Guidelines on Prostate Cancer

The European Association of Urology (EAU) Guidelines Group for Prostate Cancer have prepared this guidelines document to assist medical professionals...

Added 1 year ago

Guidelines on the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS)

Recommendations apply to men aged 40 years or older who seek professional help for various non-neurogenic benign forms of LUTS...

Added 1 year ago

Search all guidelines for Men's health/andrology
 

Journal articles

Normalization of testosterone levels after testosterone replacement therapy is associated with decreased incidence of atrial fibrillation.

Atrial fibrillation (AF) is the most common cardiac dysrhythmia associated with significant morbidity and mortality.

Added 1 month ago

Could testosterone therapy in hypogonadal men ameliorate anemia, a cardiovascular risk factor? An observational, 54-week cumulative registry study.

In this study we investigated if testosterone undecanoate attenuates anemia and the risk of cardiovascular disease in patients with hypogonadism.

Added 2 months ago

Erythrocytosis following testosterone therapy.

A rapid increase in awareness of androgen deficiency has led to substantial increases in prescribing of testosterone therapy (TTh), with benefits of improvements in mood, libido, bone density, muscle mass, body composition, energy, and cognition.

Added 2 months ago

Search all journal articles for Men's health/andrology
 

Clinical trials

Study of abiraterone acetate plus ADT versus apalatumide versus abiraterone and apalatumide in patients with advanced prostate cancer with non-castrate testosterone levels

Evaluation of the activity, safety and patients reported outcome of ADT plus abiraterone, abiraterone plus APALUTAMIDE (a second-generation antiandrogen) or APALUTAMIDE alone in hormone naïve locally advanced...

Added 11 months ago

Olaparib with or without cediranib in treating patients with metastatic hormone-resistant prostate cancer

This randomized phase II trial studies how well olaparib with or without cediranib works in treating patients with hormone-resistant prostate cancer that has spread to other places in the body.

Added 11 months ago

Hormone therapy with or without definitive radiotherapy in metastatic prostate cancer

PART I - Hormone therapy with or without definitive radiotherapy in metastatic prostate cancer
The goal of this clinical study PART I is to determine impact of radiotherapy treatment in combination with...

Added 11 months ago

Search all clinical trials for Men's health/andrology
 

Blog Posts

Monica Caliber

Hypogonadism – why important to diagnose and treat?

Posted 1 year ago

Most clinicians and patients think that the purpose of treating hypogonadism is to merely relieve symptoms. However, this only scratches the surface... 

Hugh Harvey

Metrics Madness

Posted 1 year ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

My Urology Doc

Men's Health: A Forgotten Topic

Posted 2 years ago

Men's health is a forgotten topic. To be honest, we men are mostly to blame. We've clung to our masculine misconceptions and repeatedly refused to engage the healthcare community. Who can blame us, we're invincible and we're going to live forever, right? Well, not exactly. Let's look at some of the reasons men's health is one of the least engaged topics in healthcare. 

CME

Managing the side effects of treatment for prostate cancer

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Managing patients at risk of prostate cancer

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Guidance update: latest NICE guidelines on prostate cancer

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
154.8
Search all CME for Men's health/andrology